|
From the Cardiac Diagnostic Unit, Hospital of Saint Raphael, New Haven, Conn. (Marcu), and the Department of Cardiology, VU University Medical Centre, Amsterdam, The Netherlands (Beek, van Rossum)
Correspondence to: Dr. Constantin B. Marcu, Cardiac Diagnostic Unit, Hospital of Saint Raphael, 1450 Chapel St, New Haven CT 06511, USA; bogmarcu{at}pol.net
Abstract
Cardiovascular magnetic resonance imaging (MRI) has evolved from an effective research tool into a clinically proven, safe and comprehensive imaging modality. It provides anatomic and functional information in acquired and congenital heart disease and is the most precise technique for quantification of ventricular volumes, function and mass. Owing to its excellent interstudy reproducibility, cardiovascular MRI is the optimal method for assessment of changes in ventricular parameters after therapeutic intervention. Delayed contrast enhancement is an accurate and robust method used in the diagnosis of ischemic and nonischemic cardiomyopathies and less common diseases, such as cardiac sarcoidosis and myocarditis. First-pass magnetic contrast myocardial perfusion is becoming an alternative to radionuclide techniques for the detection of coronary atherosclerotic disease. In this review we outline the techniques used in cardiovascular MRI and discuss the most common clinical applications.
This article has been cited by other articles:
![]() |
P. G. Chan, M. P. Smith, T. H. Hauser, S. B. Yeon, E. Appelbaum, N. M. Rofsky, and W. J. Manning Noncardiac Pathology on Clinical Cardiac Magnetic Resonance Imaging J. Am. Coll. Cardiol. Img., August 1, 2009; 2(8): 980 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Benza, R. Biederman, S. Murali, and H. Gupta Role of Cardiac Magnetic Resonance Imaging in the Management of Patients With Pulmonary Arterial Hypertension J. Am. Coll. Cardiol., November 18, 2008; 52(21): 1683 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. COLANGELO and D. L WRIGHT Sarcoidosis: A Primer Radiol. Technol., September 1, 2008; 80(1): 49 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Roguin, J. Schwitter, C. Vahlhaus, M. Lombardi, J. Brugada, P. Vardas, A. Auricchio, S. Priori, and T. Sommer Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices Europace, March 1, 2008; 10(3): 336 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Agabiti-Rosei, M. L. Muiesan, and M. Salvetti Review: New approaches to the assessment of left ventricular hypertrophy Therapeutic Advances in Cardiovascular Disease, December 1, 2007; 1(2): 119 - 128. [Abstract] [PDF] |
||||